Bulletin
Innovation and Intellectual Property (IP) in sports nutrition: Patents, freedom to operate and commercial strategy
Subscribe to our insights here so you can keep on top of the latest IP developments and updates.
Innovation and Intellectual Property (IP) in sports nutrition: Patents, freedom to operate and commercial strategy
UK design law set for refresh: Government unveils plans to modernise protection and tackle bad-faith filings
Reform of the UK Clinical Trial Regulations: making the UK a premier destination for clinical research?
Patenting for the life sciences industry: Choosing which countries to file in
So, it's a date: High Court confirms that the EUTM filing date is the relevant date for assessing absolute grounds for UK trade marks filed under Article 59(1) of the UK-EU Withdrawal Agreement
Patenting agrochemicals in Europe: key challenges and opportunities for innovators
Boult ranked Band 1 by Chambers and Partners UK for 2027
Boult recognised in Tier 1 by Legal 500 2027
Omnia v Sidel appeal confirms: if you intend to opt out, do it early
From formulations to ingredients: how consumer behaviour is changing skincare patent strategy
The UK-Swiss trade deal: boosting innovation in pharma and biotech
The freedom to operate questions every deep-tech company should ask
Cheers! UAE opens the door to trade mark registration for alcoholic beverages
EPO v UPC – jurisdiction
Circular beauty: the chemistry and packaging innovations driving sustainable cosmetics
From lab to manufacturing: why scale-up can create new patent opportunities
EPO vs UPC: Procedural considerations for EPO oppositions and UPC revocation action proceedings
Trade mark pitfalls when launching new products internationally: how Boult’s Spanish team can help you avoid costly mistakes
Intellectual property challenges for university spin-outs in chemistry and climate technology
G 1/25 decision - description amendments are required, but in more limited cases
Boult is pleased to announce that the firm has once again been ranked Band 1 by Chambers and Partners UK for both
Boult ranked in Tier 1 by Legal 500 in the 2027 PATMA rankings for both patent attorneys and trade mark attorneys.
Boult is pleased to announce that it has been ranked as “Outstanding” for non-contentious patent matters by the World Intellectual Property Review (WIPR) for 2026.
Boult is proud to be recognised in Lexology Index: IP 2026, with Dr Catherine Wolfe named a Global Elite Thought Leader and multiple partners ranked across the prestigious report.
Boult is pleased to announce that the firm has once again been ranked Band 1 by Chambers and Partners UK for both
Boult ranked in Tier 1 by Legal 500 in the 2027 PATMA rankings for both patent attorneys and trade mark attorneys.
Boult is pleased to announce that it has been ranked as “Outstanding” for non-contentious patent matters by the World Intellectual Property Review (WIPR) for 2026.
Boult is proud to be recognised in Lexology Index: IP 2026, with Dr Catherine Wolfe named a Global Elite Thought Leader and multiple partners ranked across the prestigious report.